Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2016
The Role of Local Triplet Excited States and D-A Relative Orientation in Thermally Activated Delayed Fluorescence: Photophysics and DevicesFernando B Dias, Jose Santos, David R Graves, et al.Life Sciences|December 26, 2021
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myelomaRebecca Amet, Viola Previtali, Helene B Mihigo, et al.Journal of the International AIDS Society|November 14, 2014
CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-studyIgnacio Pérez Valero, Juan Pasquau, Rafael Rubio, et al.Cureus|November 16, 2022
Clinical, Therapeutic, and Prognostic Experience in Patients With GlioblastomaMichel Mondragon-Soto, Luis A Rodríguez-Hernández, Sergio Moreno Jiménez, et al.RMD Open|November 30, 2018
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registriesKim Lauper, Denis Mongin, Florenzo Iannone, et al.Asian Pacific Journal of Cancer Prevention : APJCP|June 21, 2025
Scored Patient-Generated Subjective Global Assessment (PG-SGA) in Brazilian Cancer Patients and Association with Anthropometric ParametersOdara Maria De Sousa Sa, Ana Karoline Ferreira Dos Santos, Thayssa Lauanna Vitória E Silva Santos, et al.Journal of Nursing Measurement|May 11, 2026
Using the Novel Translation Validity Index to Evaluate GenAI Translations of the Patient Health Questionnaire-9 Into Nine LanguagesRatchneewan Ross, Lenny Chiang-Hanisko, Said Abusalem, et al.Annals of the Rheumatic Diseases|May 7, 2018
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaborationKim Lauper, Dan C Nordström, Karel Pavelka, et al.Journal of Medicinal Chemistry|October 14, 2009
Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groupsMichael Jones, Iwona Inkielewicz, Carlos Medina, et al.RMD Open|November 25, 2021
Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseasesFilipa Oliveira Ramos, Ana Rodrigues, Fernando Magalhaes Martins, et al.Pageof 11